Cargando…

Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2

T-regulatory cells (T(regs)) are a rare lymphocyte subtype that shows promise for treating infectious disease, allergy, graft-versus-host disease, autoimmunity, and asthma. Clinical applications of T(regs) have not been fully realized because standard methods of expansion ex vivo produce heterogeneo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okubo, Yoshiaki, Mera, Toshiyuki, Wang, Limei, Faustman, Denise L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818650/ https://www.ncbi.nlm.nih.gov/pubmed/24193319 http://dx.doi.org/10.1038/srep03153

Ejemplares similares

Tumor Necrosis Factor and Regulatory T Cells
por: Jung, Min Kyung, et al.
Publicado: (2019)

Novel Automated Blood Separations Validate Whole Cell Biomarkers
por: Burger, Douglas E., et al.
Publicado: (2011)

Treg activation defect in type 1 diabetes: correction with TNFR2 agonism
por: Okubo, Yoshiaki, et al.
Publicado: (2016)

Tumor necrosis factor receptor family costimulation increases regulatory T‐cell activation and function via NF‐κB
por: Lubrano di Ricco, Martina, et al.
Publicado: (2020)

Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
por: Salomon, Benoît L., et al.
Publicado: (2018)

Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2
por: Miao, Kun, et al.
Publicado: (2020)

Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling
por: Ban, Liqin, et al.
Publicado: (2015)

Shedding of tumor necrosis factor receptors by activated human neutrophils
Publicado: (1990)

Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes
por: Faustman, Denise L., et al.
Publicado: (2012)

Tumor necrosis factor receptor superfamily costimulation couples T cell receptor signal strength to thymic regulatory T cell differentiation
por: Mahmud, Shawn A., et al.
Publicado: (2014)

Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
por: Endo, S, et al.
Publicado: (2000)

Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured With an Ultrasensitive C-peptide Assay
por: Wang, Limei, et al.
Publicado: (2012)

Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer
por: Wajant, Harald, et al.
Publicado: (2019)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Fischer, Roman, et al.
Publicado: (2017)

Dipyridamole Combined with Tumor Necrosis Factor‐α Enhances Inhibition of Proliferation in Human Tumor Cell Lines
por: Suzuki, Nobuo, et al.
Publicado: (1995)

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
por: Schaer, David A, et al.
Publicado: (2014)

The benefits of clustering in TNF receptor superfamily signaling
por: Vanamee, Éva S., et al.
Publicado: (2023)

TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine
por: Faustman, Denise L., et al.
Publicado: (2013)

Production of Tumor Necrosis Factor‐α by Alveolar Macrophages of Lung Cancer Patients
por: Okubo, Akio, et al.
Publicado: (1990)

An expansive human regulatory lexicon encoded in transcription factor footprints
por: Neph, Shane, et al.
Publicado: (2012)

Tumor necrosis factor receptor-mediated signaling pathways
Publicado: (1994)

The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4(+)Foxp3(+) Regulatory T Cells
por: He, Tianzhen, et al.
Publicado: (2018)

Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
por: Lim, Mie Jin, et al.
Publicado: (2014)

Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
por: Mukaro, Violet R., et al.
Publicado: (2018)

Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
por: Yang, Nicole, et al.
Publicado: (2019)

Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
por: Kitaura, Hideki, et al.
Publicado: (2022)

RNPS1 inhibits excessive tumor necrosis factor/tumor necrosis factor receptor signaling to support hematopoiesis in mice
por: Zhong, Xue, et al.
Publicado: (2022)

The expression of tumor necrosis factor-alpha, its receptors and steroidogenic acute regulatory protein during corpus luteum regression
por: Abdo, Michael, et al.
Publicado: (2008)

The Significance of Tumor Necrosis Factor Receptor Type II in CD8(+) Regulatory T Cells and CD8(+) Effector T Cells
por: Ye, Lin-Lin, et al.
Publicado: (2018)

Synthetic Nanoparticles That Promote Tumor Necrosis Factor Receptor 2 Expressing Regulatory T Cells in the Lung and Resistance to Allergic Airways Inflammation
por: Mohamud, Rohimah, et al.
Publicado: (2017)

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
Publicado: (1992)

Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy
por: Bremer, Edwin
Publicado: (2013)

Inhibition of tumor necrosis factor receptor 1 and the risk of periodontitis
por: Alayash, Zoheir, et al.
Publicado: (2023)

Study of tumor necrosis factor receptor in the inflammatory bowel disease
por: Souza, Roberta Figueiroa, et al.
Publicado: (2023)

Tumor necrosis factor-alpha in normal and diseased brain: Conflicting effects via intraneuronal receptor crosstalk?
por: Perry, Seth W., et al.
Publicado: (2002)

Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies
por: Lang, Isabell, et al.
Publicado: (2018)

Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
por: Kucka, Kirstin, et al.
Publicado: (2021)

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
por: Zaitseva, Olena, et al.
Publicado: (2023)

TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
por: Sheng, Yuqiao, et al.
Publicado: (2018)

Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_pc1f7bgavbuo31n8rcj90e8abe